BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19453983)

  • 1. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
    Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
    Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.
    Kakaiya RM; Triulzi DJ; Wright DJ; Steele WR; Kleinman SH; Busch MP; Norris PJ; Hillyer CD; Gottschall JL; Rios JA; Carey P; Glynn SA;
    Transfusion; 2010 Jun; 50(6):1328-34. PubMed ID: 20070615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of specificities of antibodies against human leukocyte antigens in blood donors.
    Endres RO; Kleinman SH; Carrick DM; Steele WR; Wright DJ; Norris PJ; Triulzi D; Kakaiya R; Busch MP;
    Transfusion; 2010 Aug; 50(8):1749-60. PubMed ID: 20158682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor screening as a TRALI risk reduction strategy.
    Murphy MF; Navarrete C; Massey E
    Transfusion; 2009 Sep; 49(9):1779-82. PubMed ID: 19735501
    [No Abstract]   [Full Text] [Related]  

  • 10. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
    Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
    Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
    van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
    Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.
    Quillen K; Medrano C; Adams S; Peterson B; Hackett J; Leitman SF; Klein HG; Stroncek DF
    Transfusion; 2011 Mar; 51(3):504-10. PubMed ID: 20849407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human leukocyte antigen antibodies are present in blood of blood donors: is therapy with blood preparations safe for graft recipients?
    Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Krasnodębska-Szponder B; Kłosińska E; Agapow A; Giedrys-Kalemba S
    Transplant Proc; 2014 Oct; 46(8):2565-71. PubMed ID: 25380867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population.
    Gottschall JL; Triulzi DJ; Curtis B; Kakaiya RM; Busch MP; Norris PJ; Glynn SA; Carrick D; Wright DJ; Kleinman S;
    Transfusion; 2011 Apr; 51(4):820-7. PubMed ID: 20977484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.